Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001209191-20-004828

Options or other derivatives

  • SVP, Chief Business Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Girard Armand · SVP, Chief Business Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-01-22 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X03/doc4.xml…